RACIOPPI, LUIGI
RACIOPPI, LUIGI
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Modulation of CD45 tyrosine phosphatase activity by antigen.
2001 LAGO PAZ, F; Galgani, M; D'Oro, U; Matarese, G; Masci, Am; Zappacosta, S; Racioppi, Luigi
The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling
1996 Racioppi, Luigi; Matarese, M; D'Oro, U; DE PASCALE, Mt; Masci, Am; Fontana, S.; Zappacosta, S.
The molecular basis of class II MHC allelic control of T cell responses.
1991 Racioppi, Luigi; Ronchese, F; Schwartz, Rh; Germain, Rn
The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
1993 Boehncke, Wh; Takeshita, T; Pendleton, Cd; Houghten, Ra; SADEGH NASSERI, S; Racioppi, Luigi; Berzofsky, Ja; Germain, Rn
HLA class II molecules transduce accessory signals affecting the CD3, but not IL-2 activation pathaway in T blast.
1993 Di Rosa, F.; D’Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Ferrone, S.; Fontana, S.; Zappacosta, S.
Major Histocompatibility Complex Class II molecules transduce activation signals in Human T blasts.
1992 D’Oro, U; Di Rosa, F.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Chianca, R; Ferrone, S.; Fontana, S.; Zappacosta, S.
The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.
2012 Barberi, Tj; Dunkle, A; He, Yw; Racioppi, Luigi; Means, Ar
Fatal immunodeficiency in a patient with thymoma and Good's syndrome.
2005 Montella, Liliana; Merkabaoui, G; Vitiello, L; Bulgarelli, G; Sinagra, G; Masci, Am; Racioppi, Luigi; Palmieri, Giovannella
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation.
2011 Cancrini, C.; Scarselli, A.; Scaramuzza, S.; Chiriaco, M.; Di Cesare, S.; Di Matteo, G.; Romiti, M. L.; Palma, P.; De Felice, L.; Palumbo, G.; Pinto, R. M.; De Vito, R.; Racioppi, Luigi; Livadiotti, S.; Fischer, A.; Rossi, P.; Caniglia, M.; Aiuti, A.
CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem
2013 Racioppi, Luigi
Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate.
2008 Racioppi, Luigi
Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level
1990 Racioppi, Luigi; Moscarella, A; Ruggiero, Giuseppina; Manzo, C; Ferrone, S; Fontana, S; Zappacosta,
HLA Class II molecules trabsduce accessory signals affecting the CD3 but not the intreleukin-2 activation pathway in T blasts
1993 DI ROSA, F.; D'Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A. M.; Ferrone, S.; Fontana, S.; Zappacosta, S.
Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.
2003 Frasca, L; Scotta, C; DEL PORTO, P; Nicosia, A; Pasquazzi, C; Versace, I; Masci, Am; Racioppi, Luigi; Piccolella, E.
HLA class II molecules transduce accessory signals affecting the CD3 but not the interleukin-2 activation pathway in T blasts. PMID: 8138420 [PubMed - indexed for MEDLINE]
1993 DI ROSA, F; D'Oro, U; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A; Ferrone, S; Fontana, S; Zappacosta, S.
IMMUNOLOGICAL FINDINGS IN THYMOMA AND THYMOMA-RELATED SYNDROMES
1999 Masci, Am; Palmieri, G; Perno, F; Montella, L; Racioppi, Luigi
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling
1993 Racioppi, Luigi; Ronchese, F; Matis, La; Germain, Rn
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
2007 Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo
Human equivalent of the mouse nude/SCID phenotype: Long-term evolvation of immunological reconstitution after bone marrow transplantation.
2001 Pignata, Claudio; Gaetaniello, L.; Masci, A. M.; Frank, J.; Christiano, A.; Matrecano, E.; Racioppi, Luigi
HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling
2003 Masci, Am; Galgani, M; Cassano, S; De Simone, S; Gallo, A; De Rosa, V; Zappacosta, S; Racioppi, Luigi
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Modulation of CD45 tyrosine phosphatase activity by antigen. | 1.1 Articolo in rivista | 2001 | LAGO PAZ, F; Galgani, M; D'Oro, U; Matarese, G; Masci, Am; Zappacosta, S; Racioppi, Luigi | |
| The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling | 1.1 Articolo in rivista | 1996 | Racioppi, Luigi; Matarese, M; D'Oro, U; DE PASCALE, Mt; Masci, Am; Fontana, S.; Zappacosta, S. | |
| The molecular basis of class II MHC allelic control of T cell responses. | 1.1 Articolo in rivista | 1991 | Racioppi, Luigi; Ronchese, F; Schwartz, Rh; Germain, Rn | |
| The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. | 1.1 Articolo in rivista | 1993 | Boehncke, Wh; Takeshita, T; Pendleton, Cd; Houghten, Ra; SADEGH NASSERI, S; Racioppi, Luigi; Berzofsky, Ja; Germain, Rn | |
| HLA class II molecules transduce accessory signals affecting the CD3, but not IL-2 activation pathaway in T blast. | 1.1 Articolo in rivista | 1993 | Di Rosa, F.; D’Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| Major Histocompatibility Complex Class II molecules transduce activation signals in Human T blasts. | 2.1 Contributo in volume (Capitolo o Saggio) | 1992 | D’Oro, U; Di Rosa, F.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Chianca, R; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice. | 1.1 Articolo in rivista | 2012 | Barberi, Tj; Dunkle, A; He, Yw; Racioppi, Luigi; Means, Ar | |
| Fatal immunodeficiency in a patient with thymoma and Good's syndrome. | 1.1 Articolo in rivista | 2005 | Montella, Liliana; Merkabaoui, G; Vitiello, L; Bulgarelli, G; Sinagra, G; Masci, Am; Racioppi, Luigi; Palmieri, Giovannella | |
| Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. | 1.1 Articolo in rivista | 2011 | Cancrini, C.; Scarselli, A.; Scaramuzza, S.; Chiriaco, M.; Di Cesare, S.; Di Matteo, G.; Romiti, M. L.; Palma, P.; De Felice, L.; Palumbo, G.; Pinto, R. M.; De Vito, R.; Racioppi, Luigi; Livadiotti, S.; Fischer, A.; Rossi, P.; Caniglia, M.; Aiuti, A. | |
| CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem | 1.1 Articolo in rivista | 2013 | Racioppi, Luigi | |
| Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate. | 8.03 Conv. e contr. di ricerca di Enti Pubblici/Privati | 2008 | Racioppi, Luigi | |
| Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level | 1.1 Articolo in rivista | 1990 | Racioppi, Luigi; Moscarella, A; Ruggiero, Giuseppina; Manzo, C; Ferrone, S; Fontana, S; Zappacosta, | |
| HLA Class II molecules trabsduce accessory signals affecting the CD3 but not the intreleukin-2 activation pathway in T blasts | 1.1 Articolo in rivista | 1993 | DI ROSA, F.; D'Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A. M.; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes. | 1.1 Articolo in rivista | 2003 | Frasca, L; Scotta, C; DEL PORTO, P; Nicosia, A; Pasquazzi, C; Versace, I; Masci, Am; Racioppi, Luigi; Piccolella, E. | |
| HLA class II molecules transduce accessory signals affecting the CD3 but not the interleukin-2 activation pathway in T blasts. PMID: 8138420 [PubMed - indexed for MEDLINE] | 1.1 Articolo in rivista | 1993 | DI ROSA, F; D'Oro, U; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A; Ferrone, S; Fontana, S; Zappacosta, S. | |
| IMMUNOLOGICAL FINDINGS IN THYMOMA AND THYMOMA-RELATED SYNDROMES | 1.1 Articolo in rivista | 1999 | Masci, Am; Palmieri, G; Perno, F; Montella, L; Racioppi, Luigi | |
| Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling | 1.1 Articolo in rivista | 1993 | Racioppi, Luigi; Ronchese, F; Matis, La; Germain, Rn | |
| TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. | 1.1 Articolo in rivista | 2007 | Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo | |
| Human equivalent of the mouse nude/SCID phenotype: Long-term evolvation of immunological reconstitution after bone marrow transplantation. | 1.1 Articolo in rivista | 2001 | Pignata, Claudio; Gaetaniello, L.; Masci, A. M.; Frank, J.; Christiano, A.; Matrecano, E.; Racioppi, Luigi | |
| HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling | 1.1 Articolo in rivista | 2003 | Masci, Am; Galgani, M; Cassano, S; De Simone, S; Gallo, A; De Rosa, V; Zappacosta, S; Racioppi, Luigi |